Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
The British Journal of Dermatology
|
May 16, 2017
Epidermal growth factor receptor gaining impact in cutaneous squamous cell carcinoma
K G Griewank
Der Pathologe
|
December 11, 2014
[Molecular diagnostics of melanomas]
K G Griewank
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
June 9, 2016
[Molecular and immunohistochemical diagnostics in melanoma]
B Schilling, K G Griewank
Der Internist
|
May 29, 2020
[Immunotherapy for malignant melanoma]
A Zaremba, L Zimmer, K G Griewank, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2014
Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Diwakar et al
B Schilling, W Sondermann, K G Griewank, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
November 28, 2018
[Digital papillary adenocarcinoma : Four case reports with brief literature review]
L Held, T Mentzel, B E Paredes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 2, 2021
Management of partial and non-responding cutaneous squamous cell carcinoma
P Jansen, G C Lodde, K G Griewank, et al.
Pigment Cell & Melanoma Research
|
January 13, 2012
Genetic and molecular characterization of uveal melanoma cell lines
K G Griewank, X Yu, J Khalili, et al.
British Journal of Cancer
|
June 27, 2013
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
K G Griewank, R Murali, B Schilling, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 2, 2021
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors
P Jansen, G C Lodde, A Wetter, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
The British Journal of Dermatology
|
May 16, 2017
Epidermal growth factor receptor gaining impact in cutaneous squamous cell carcinoma
K G Griewank
Der Pathologe
|
December 11, 2014
[Molecular diagnostics of melanomas]
K G Griewank
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
June 9, 2016
[Molecular and immunohistochemical diagnostics in melanoma]
B Schilling, K G Griewank
Der Internist
|
May 29, 2020
[Immunotherapy for malignant melanoma]
A Zaremba, L Zimmer, K G Griewank, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2014
Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Diwakar et al
B Schilling, W Sondermann, K G Griewank, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
November 28, 2018
[Digital papillary adenocarcinoma : Four case reports with brief literature review]
L Held, T Mentzel, B E Paredes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 2, 2021
Management of partial and non-responding cutaneous squamous cell carcinoma
P Jansen, G C Lodde, K G Griewank, et al.
Pigment Cell & Melanoma Research
|
January 13, 2012
Genetic and molecular characterization of uveal melanoma cell lines
K G Griewank, X Yu, J Khalili, et al.
British Journal of Cancer
|
June 27, 2013
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
K G Griewank, R Murali, B Schilling, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 2, 2021
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors
P Jansen, G C Lodde, A Wetter, et al.
Page
of 2